RCKT — Rocket Pharmaceuticals Share News
0.000.00%
Last trade - 00:00- $251.38m
- -$11.09m
U.S. STOCKS ON THE MOVE-ServiceNow, PoolCorp, Rocket Pharma
Rocket Pharma climbs after cutting workforce by 30%
Brief: Rocket Pharmaceuticals Receives FDA Regenerative Medicine Advanced Therapy (Rmat) Designation For Rp-A601 Gene Therapy For Pkp2-Arrhythmogenic Cardiomyopathy
Brief: Rocket Pharmaceuticals Phase 1 Trial To Evaluate Safety And Efficacy Of Rp-A701
U.S. RESEARCH ROUNDUP-Claritev, Rocket Pharmaceuticals, Salesforce
U.S. RESEARCH ROUNDUP-Autozone, Rocket Pharmaceuticals, Travelers
U.S. STOCKS ON THE MOVE- AMC,Natgas companies,Hologic
U.S. STOCKS ON THE MOVE-BellRing, Coeur, AMC Entertainment
Rocket Pharma hits record low after patient death during gene therapy trial
U.S. STOCKS ON THE MOVE-Southwest Airlines, Informatica, Oklo
Rocket Pharma sinks after patient death, US FDA's clinical hold on gene therapy trial
Brief: Rocket Pharmaceuticals Provides Update On Phase 2 Clinical Trial Of Rp-A501 For Danon Disease
US FDA pauses gene therapy trial by Rocket Pharma after patient death (updated)
US FDA places clinical hold on Rocket Pharma's gene therapy trial
Brief: Rocket Pharmaceuticals Presents Preliminary Data From Phase 1 Clinical Trial of RP-A601 For PKP2 Arrhythmogenic Cardiomyopathy At 28th Annual Meeting Of The American Society Of Gene And Cell Therapy
Rocket Pharmaceuticals Inc reports results for the quarter ended March 31 - Earnings Summary
Brief: Rocket Pharmaceuticals Q1 Basic EPS USD -0.56
Rocket Pharmaceuticals Inc reports results for the quarter ended December 31 - Earnings Summary
U.S. STOCKS ON THE MOVE-Gold miners, Tesla, ADM